Germany recently passed a reform bill for the Patent Act (PatG) and its new provisions will likely be coming into force sooner rather than later. The reform is particularly relevant for companies from the life sciences sector, which often litigate…
Continue Reading German Patents Act (PatG) Receives New Updates

A task force, composed of key antitrust enforcement agencies including the Federal Trade Commission (FTC), and the Canadian Competition Bureau, is seeking information from the public regarding the effects of pharmaceutical mergers. This information will be used to update the…
Continue Reading A multi-agency pharmaceutical task force looks to review antitrust issues that arise during mergers and acquisitions

Reed Smith is pleased to present a virtual life sciences CLE week from November 9 – 13, covering hot litigation and regulatory topics of interest to our pharmaceutical, biotech, and medical device clients. Sessions include:

• The ABCs of an MDL:

…
Continue Reading Join Us: Virtual Life Sciences CLE Week for In-House Counsel: November 9-13

As part of the Greater Philadelphia chapter of the Association of Corporate Counsel’s Litigation Law CLE Week, I am pleased to be joining my Reed Smith colleague Jim Beck and Endo Pharmaceuticals’ Vice President and Assistant General Counsel – Litigation…
Continue Reading Join Us for a CLE Webinar on Strategies for Addressing Common, but Seldom Discussed, Mass Tort Litigation Irritants

The CARES Act funding was a lifeline for many health care organizations and life sciences companies, but came with significant attached strings. Related fraud charges are already making headlines and bring with them the serious risk of False Claims Act…
Continue Reading Please join us for an upcoming CLE webinar, “Preparing for the inevitable: FCA investigations in a post-COVID world”

While the life sciences sector has proven more resilient than most, COVID-19 has undoubtedly caused a dramatic slowdown in deal activity globally across industries. Please join Reed Smith and a panel of strategic, private equity, and venture capital leading deal…
Continue Reading Reed Smith hosts July 16 life sciences virtual roundtable on “Deal making in a post-COVID world”

The German Federal Ministry for Economic Affairs and Energy implemented further amendments to the Foreign Trade and Payments Ordinance (Außenwirtschaftsverordnung – AWV) due to the COVID-19 pandemic to prevent the buyout of German companies active in the life sciences and…
Continue Reading COVID-19 pandemic: German government further extends foreign investment control rules with regard to transactions in the life sciences sector